Results 171 to 180 of about 12,043,843 (293)

Antihypertensive treatment with hydrochlorothiazide-hydralazine combination aggravates medial vascular calcification in CKD rats with mineral bone disorder. [PDF]

Front Cardiovasc Med, 2023
Larivière R, Ung RV, Picard S, Richard DE, Mac-Way F, Agharazii M.   +5 more
europepmc   +1 more source

Treatment of hypertensive patients with mebutamate, a new antihypertensive drug. A preliminary study.

, 1962
John L. S. Holloman
openalex   +2 more sources

Exploring the roles and impacts of pharmacists embedded in general practice: a scoping review

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background The role of the general practice pharmacist (GPP) in Australia is not yet clearly defined, and their clinical expertise remains underutilised in general practice settings. This may be attributed to a limited understanding of pharmacists' capabilities, which can hinder optimal GPP utilisation.
Christel Chandra, Brooke Bevis, Nazanin Falconer, Holly Foot   +3 more
wiley   +1 more source

Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats. [PDF]

Sci Rep, 2023
Naessens DMP, de Vos J, Richard E, Wilhelmus MMM, Jongenelen CAM, Scholl ER, van der Wel NN, Heijst JA, Teunissen CE, Strijkers GJ, Coolen BF, VanBavel E, Bakker ENTP.   +12 more
europepmc   +1 more source

Atlas project: a global pharmacoeconomical evaluation of antihypertensive treatment [PDF]

, 1999
E DEGLIESPOSTI
openalex   +1 more source

Pyoderma Gangrenosum Associated With Major Adverse Cardiovascular Events

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a neutrophilic dermatosis characterized by the rapid onset of painful ulcers. Previous retrospective population‐based studies have identified a relationship between PG and major adverse cardiovascular events (MACE).
Nana Ama Adjei‐Frimpong, Francesco Delacqua, Ben A. Croker, Reid Oldenburg   +3 more
wiley   +1 more source

Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLD

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study investigates the impact of cardiometabolic risk factors (CMRF) on the prevalence and incidence of hypertension (HTN) and diabetes mellitus (DM) in individuals with metabolic dysfunction‐associated steatotic liver disease (MASLD) and nonsteatotic liver disease (non‐SLD), using both cross‐sectional and longitudinal data. A total of 32,
Chin‐I Shih, Ming‐Lun Yeh, Yi‐Hung Lin, Ping‐Tsung Shih, Kuan‐Ta Wu, Meng‐Hsuan Hsieh, Jeng‐Fu Yang, Yi‐Yu Chen, Po‐Cheng Liang, Yu‐Ju Wei, Pei‐Chien Tsai, Ya‐Yun Cheng, Ming‐Yen Hsieh, Chih‐Wen Wang, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Chi‐Kung Ho, Wan‐Long Chuang, Vincent Wai‐Sun Wong, Wei‐Ting Chang, Ming‐Lung Yu   +21 more
wiley   +1 more source

Impact of Hypertension and Antihypertensive Treatment on COVID-19 Severity: A Retrospective Observational Study in Ternopil Region, Ukraine. [PDF]

Ther Clin Risk Manag
Hrebenyk M, Maslii S, Shevchuk O, Komorovsky R, Korda M.   +4 more
europepmc   +1 more source

N-of-1 Trials for Pediatric Hypertension? A Promising Approach to Increasing the Precision of Antihypertensive Treatment. [PDF]

Am J Hypertens, 2023
Goyal P, Kronish IM.
europepmc   +1 more source

Renal insufficiency : Aiming at prevention and progress.3.Chronic advanced renal insufficiency.3.Significance and treatment of antihypertensive agents in chronic advanced renal disturbance.

, 1993
藤原 芳廣
openalex   +2 more sources